Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cefuroxime intracameral flushing vs conventional technique in phacoemulsification cataract surgery
TCTR20260121001Phase 4Completed
- Sponsor
- -
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cefuroxime in endophthalmitis (2 arms). Primary endpoint: Safety profile. Started Aug 2022; status: completed.
02
Drugs
cefuroxime
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on TCTR20260121001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260121001.